Pfizer ($PFE) Q2 adjusted EPS of $0.77 beats estimates of $0.68; revenue of $15.03B beats estimates of $14.41B, maintains FY revenue outlook. The company reported a net loss of $248 million for the quarter, with GAAP EPS at -$0.04.